Management of Severe Insulin Resistance in Patients with Type 1 Diabetes
The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
Managing severe insulin resistance (IR) in patients with type 1 diabetes (T1DM) can be challenging for both clinicians and patients. As average weight for patients with T1DM has increased in recent decades, IR in this population has become more widespread. Currently, almost 50 % of patients with T1DM are overweight or obese. While intensive insulin therapy is associated with reduction in complications, aggressive treatment can lead to weight gain. With increasing weight, insulin can become less effective to control glycemia, resulting in higher insulin doses and hence more weight gain. Novel strategies to break this vicious cycle are needed. This review will investigate current research on insulin formulations, lifestyle modification, adjunct therapies, and surgery that may help better manage patients with T1DM and IR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in people with established type 1 diabetes, presence of obesity can worsen insulin resistance, glycemic variability, microvascular disease complications, and cardiovascular risk factors (184 -188).”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [185]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Sjöström, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12012 · Cited by 1,835
Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200111 · Cited by 1,791
Ogden, C. L., Yanovski, S. Z., Carroll, M. D., & Flegal, K. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.052 · Cited by 1,561
Glycemic Control and Excess Mortality in Type 1 Diabetes
Lind, M., Svensson, A.-M., Kosiborod, M., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Dahlqvist, S., Clements, M., & Rosengren, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408214 · Cited by 964
α-Glucosidase Inhibitors for Patients With Type 2 Diabetes
van de Laar, F. A., Lucassen, P. L., Akkermans, R. P., van de Lisdonk, E. H., Rutten, G. E., & van Weel, C. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.154 · Cited by 690
Research works printed but not linked: 3
- Garg R, Lawrence IG, Akinsola MO, Davies MJ, McNally PG. Improved glycaemic control in severely insulin resistant, insulin treated diabetic patients with U500 human actrapid over 2 years follow-up. Diabetologia. 2004;47 Suppl 1:A58.
- Nayyar V, Lawrence IG, Kong MF, Gallagher A, Gregory R, Hiles S, et al. Long-term follow-up of patietns on U-500 human actrapid. Diabetologia. 2007;50(Suppl1):S538.
- Matsuhisa M, Koyama M, Cheng X, Shimizu S, Hirose T, EDITION JP1 Study Group. New insulin glargine 300 U/mL: glycemic control and hypoglycemia in Japanese people with T1DM (edition JP 1). Diabetes. 2014;63 Suppl 1:LB22. An open-label study compared Gla-300 vs. Gal-100 in 243 Japanese patients with T1DM for 6 months. Both insulins resulted in similar HbA1c reduction, with less confirmed or severe nocturnal hypoglycemic events with Gla-300, particularly in the first 8 weeks.
Cited by
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Weight management in patients with type 1 diabetes and obesity
Mottalib, A., Kasetty, M., Mar, J. Y., Elseaidy, T., Ashrafzadeh, S., & Hamdy, O. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0918-8 · Cited by 149
Yang, D., Zhou, J., Garstka, M. A., Xu, Q., Li, Q., Wang, L., Ren, L., Ji, Q., & Liu, T. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02736-2 · Cited by 23
Zeng, J., Liu, H.-B., Ping, F., Li, W., & Li, Y. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.02.003 · Cited by 20
McDonald, M. W., Dotzert, M. S., Jiang, M., Murray, M. R., Noble, E. G., & Melling, C. W. J. (2018) · Journal of Diabetes Research · doi:10.1155/2018/8485624 · Cited by 10
Metadata
- Authors
- Schechter, R., & Reutrakul, S.
- Affiliations
- Mahidol University (TH)
- Corresponding author
- Reutrakul, Sirimon
- ORCID
- Reutrakul, Sirimon
- Venue
- Current Diabetes Reports
- Published
- 2015-08-21
- Volume
- 15
- Issue
- 10
- Pages
- 77-77
- ISSN
- 1534-4827 (ISSN-L)
- 1539-0829
- OpenAlex
- W1143305783
- Cited by
- 15
- References
- 102
- Citations by year
- 2025: 2 · 2023: 1 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 2
- FWCI
- 0.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Diabetes Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin resistance, type 1 diabetes, obesity, weight gain, intensive insulin therapy, insulin formulations, lifestyle modification, adjunctive therapy, bariatric surgery, glycemic control
- MeSH terms
- Diabetes Mellitus, Type 1, Diet, Diet Therapy, Exercise Therapy, Humans, Insulin, Insulin Resistance, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of Severe Insulin Resistance in Patients with Type 1 Diabetes. https://app.cochat.ai/papers/10.1007/s11892-015-0641-2
- The paper
- Schechter, R., & Reutrakul, S. (2015). Management of Severe Insulin Resistance in Patients with Type 1 Diabetes. Current Diabetes Reports. https://doi.org/10.1007/s11892-015-0641-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.